Company ProPhase Labs, Inc.

Equities

PRPH

US74345W1080

Food Processing

Delayed Nasdaq 03:30:17 2024-03-28 pm EDT 5-day change 1st Jan Change
6.5 USD +3.83% Intraday chart for ProPhase Labs, Inc. +15.66% +43.81%

Business Summary

ProPhase Labs, Inc. is a diagnostics, genomics and biotech company. The Company leverages its Clinical Laboratory Improvement Amendments (CLIA) lab services to provide whole genome sequencing and research direct to consumers and build a genomics database to be used for further research. It provides traditional CLIA molecular laboratory services, including coronavirus disease (COVID-19) testing. It also operates Pharmaloz, a contract manufacturing subsidiary, which offers the TK Supplements line of dietary supplements, which are distributed in food, drug, and mass stores. The Company's wholly owned subsidiary ProPhase Diagnostics, Inc, offers a broad array of clinical diagnostic and testing services at its CLIA-certified laboratories including polymerase chain reaction (PCR) testing for SARS-CoV-2 (COVID-19) and Influenza A and Influenza B. It also owns the exclusive rights to the BE-Smart Esophageal Pre-Cancer Diagnostic Screening test.

Number of employees: 129

Sales per Business

USD in Million2021Weight2022Weight Delta
Diagnostic Services
88.3 %
69 86.7 % 108 88.3 % +58.01%
Consumer Products
11.7 %
10 13.3 % 14 11.7 % +36.58%

Sales per region

USD in Million2021Weight2022Weight Delta
United States
100.0 %
79 100.0 % 123 100.0 % +55.17%

Managers

Managers TitleAgeSince
Chief Executive Officer 64 09-06-14
Chief Operating Officer 50 Dec. 31
Comptroller/Controller/Auditor 49 22-06-30

Members of the board

Members of the board TitleAgeSince
Director/Board Member 68 09-05-31
Chief Executive Officer 64 09-06-14
Director/Board Member 44 15-05-31
Director/Board Member 66 19-05-21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 36,985,996 14,076,427 ( 38.06 %) 18,940,967 ( 51.21 %) 38.06 %

Shareholders

NameEquities%Valuation
Ted Karkus
19.86 %
3,583,750 19.86 % 16 M $
Vanguard Global Advisers LLC
3.377 %
609,347 3.377 % 3 M $
273,840 1.518 % 1 M $
Renaissance Technologies LLC
1.362 %
245,710 1.362 % 1 M $
HighTower Advisors LLC
0.9594 %
173,124 0.9594 % 773 864 $
Geode Capital Management LLC
0.7615 %
137,409 0.7615 % 614 218 $
91,450 0.5068 % 408 782 $
Perritt Capital Management, Inc.
0.4760 %
85,900 0.4760 % 383 973 $
BlackRock Institutional Trust Co. NA
0.3242 %
58,508 0.3242 % 261 531 $
SVB Wealth LLC
0.2641 %
47,665 0.2641 % 213 063 $

Holdings

NameEquities%Valuation
631,195 5.81% 3,036,048 $

Company contact information

ProPhase Labs, Inc.

711 Stewart Avenue Suite 200

11530, Garden City

+

http://www.prophaselabs.com
address ProPhase Labs, Inc.(PRPH)